Globe Newswire
Arco Vara AS informs that the list of shareholders who are entitled to dividends shall be fixed on 6th of June 2024, as at the end of the working day of Nasdaq CSD Estonian Settlement System, and therefore the dividend payment ex-date is on 5th of June 2024. From that date the new owner of the shares is not entitled to dividends for the year 2023 paid out on the 13th of June 2024.
Arco Vara AS will pay dividends to the shareholders in the net amount of 2 euro cents... (continue reading...)
AUGA Tech, UAB (hereinafter – the Company), a company indirectly owned by AUGA group, is undertaking a EUR 75 million technology development and commercialization project. The Company submitted a EUR 60 million application to the "Billion for Business" programme, administered by the National Promotional Institution INVEGA, to enable the development of its technology portfolio. The Company is also forming an impact-driven panel of external industry and financial... (continue reading...)
To Nasdaq Copenhagen A/S 3 June 2024 Announcement no. 47/2024Preliminary data on early redemptions (prepayments)Pursuant to S. 24 of the Capital Markets Act, we hereby publish preliminary data on early redemptions (prepayments) in bonds issued by Jyske Realkredit. Please find the data in the attached file.The information will also... (continue reading...)
ORION CORPORATION PRESS RELEASE 03 June 2024 at 09.30 EEST
Orion is developing the Finnish life science industry in a unique collaboration project
Orion is participating in a project led by the University of Turku for which Business Finland recently granted 11.7M€ funding. The project seeks to enhance advanced pharmaceutical and life science manufacturing in Finland. The LifeFactFuture project combines world-class-excellence of Finnish life science... (continue reading...)
PRESS RELEASEParis, 3 June 2024
Agreement reached with the government on funding of private hospitals
After two months of mass mobilisation and intense discussions with the government, a compromise was reached on 24 May 2024 between the government and the Federation of private clinics and hospitals, set out in a letter of commitment from the delegate Ministry of Health.
The Government's commitment includes, first and foremost, the principle of equal treatment between... (continue reading...)
More Globe Newswire
View Older Stories-
Flash News: OKX Announces Adjustments to Minimum Order Quantities for Select Futures Listings
-
FTI Consulting Adds Senior Chemicals Industry Expert to Further Expand Business Transformation Practice in Europe
-
Caledonia to file preliminary economic assessment on chosen approach to develop the Bilboes sulphide gold project
-
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care
-
Scatec ASA: Employee Share Purchase Programme 2024
-
Notification on the transaction concluded by manager in issuer's securities
-
Statkraft AS – Contemplating dual-currency green bond issuance
-
Pharming Group to participate in June investor conferences
-
Transaction in Own Shares
-
Voting Rights and Capital
-
Euronext completes the acquisition of Global Rate Set Systems
-
Transaction in Own Shares and Total Voting Rights
-
Total Voting Rights and Capital
-
Flash News: OKX Announces Enhancements to Portfolio Margin Mode to Optimize Trading Experience
-
BW Energy: Fixed Income Investor Meetings
-
Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer
-
Number of voting rights as of May 31, 2024
-
BW Energy: Appraisal confirms material Hibiscus field reserve increase
-
Market Update
-
Start of Day Message
-
Ontex finalizes the divestment of its business in Pakistan
-
Ipsen initiates a share buy-back program to cover its free employee share-allocation plan
-
ALK presents positive phase 3 paediatric trial data offering new hope for children with respiratory allergies
-
Corbion reports the progress of its € 20 million share buyback program 27 May – 31 May 2024
-
New data with daridorexant to be presented at SLEEP 2024
-
Flash News: OKX to Support Mina Protocol's Upgrade
-
Flash News: OKX to Support Mina Protocol's Upgrade
-
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
-
NetAlly Unveils Next Generation LinkRunner® AT Network and Cable Testers
-
BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage
-
IXOPAY Appoints Brady Harris as CEO to Drive Global Payments Growth
-
AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences
-
AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Roadmap
-
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen and EPYC Processors at Computex 2024
-
Flash News: OKX Launches 100% Fee Rebate Campaign
-
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial
-
Mesoblast Corporate Presentation at Investor Conference
-
HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
-
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
-
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
-
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
-
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting
-
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
-
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
-
Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
-
Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet